Imatinib mesylate-induced acute hepatotoxicity

被引:2
|
作者
Frikha, Imen [1 ,4 ]
Fakhfakh, Yousra [1 ]
Sahnoun, Rim [2 ]
Chtourou, Lassaad [3 ]
Medhaffar, Moez [1 ]
Elloumi, Moez [1 ]
机构
[1] Univ Sfax, Hedi Chaker Hosp, Dept Hematol, Sfax, Tunisia
[2] Univ Sfax, Fac Med Sfax, Lab Pharmacol, Sfax, Tunisia
[3] Hedi Chaker Hosp, Dept Hepatogastroenterol, Sfax, Tunisia
[4] Univ Sfax, Hedi Chaker Hosp, Dept Hematol, CHU Hedi Chaker, Sfax 3029, Tunisia
关键词
Acute hepatotoxicity; Chronic myeloid leukemia; Imatinib mesylate; CHRONIC MYELOID-LEUKEMIA;
D O I
10.1177/10781552231188307
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Imatinib is a first-line selective tyrosine kinase inhibitor used for the treatment of chronic myeloid leukemia. Although imatinib-induced hepatotoxicity may aggravate the patient's clinical condition and alter the treatment plan, the mechanism of imatinib-induced hepatotoxicity has rarely been investigated. Case report We report a 51-year-old man, suffering from acute toxic hepatitis after 5 months of imatinib treatment for chronic myeloid leukemia. Management and outcome The outcome was favorable after discontinuation of treatment with normalization of biological liver function after 12 weeks. The treatment was switched to nilotinib without any incidents. Discussion Regular liver function test monitoring is recommended during imatinib treatment. In fact of acute hepatic toxicity, treatment with imatinib should be stopped in the case of cytolysis more than five times the upper limit of normal.
引用
收藏
页码:2027 / 2030
页数:4
相关论文
共 50 条
  • [1] Early imatinib mesylate-induced hepatotoxicity in chronic myelogenous leukaemia
    Kong, Jee Hyun
    Yoo, Seung-Hyun
    Lee, Kyoung Eun
    Nam, Seung Hyun
    Kwon, Jung Mi
    Lee, Sang Min
    Chang, Hye Jung
    Choi, Moon Young
    Cho, Min Sun
    Mun, Yeung-Chul
    Nam, Eunmi
    Lee, Soon Nam
    Seong, Chu-Myong
    ACTA HAEMATOLOGICA, 2007, 118 (04) : 205 - 208
  • [2] Imatinib mesylate-induced acute cytolytic hepatitis
    Rocca, P
    El Jastimi, S
    Troncy, J
    Scoazec, JY
    Boucher, A
    Vial, T
    Trepo, C
    Zoulim, F
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2004, 28 (10): : 918 - 919
  • [3] Imatinib mesylate-induced acute hepatitis with autoimmune features
    Dhalluin-Venier, Valerie
    Besson, Caroline
    Dimet, Stephanie
    Thirot-Bibault, Anne
    Tchernia, Gilbert
    Buffet, Catherine
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2006, 18 (11) : 1235 - 1237
  • [4] Imatinib mesylate-induced interstitial pneumonitis
    Ma, CX
    Hobday, TJ
    Jett, JR
    MAYO CLINIC PROCEEDINGS, 2003, 78 (12) : 1578 - 1579
  • [5] Imatinib Mesylate-Induced Pseudoporphyria in Two Children
    Mahon, Caroline
    Purvis, Diana
    Laughton, Stephen
    Bradbeer, Peter
    Teague, Lochie
    PEDIATRIC DERMATOLOGY, 2014, 31 (05) : 603 - 607
  • [6] Imatinib mesylate-induced severe lichenoid rash
    Arshdeep
    De, Dipankar
    Malhotra, Pankaj
    Saikia, Uma Nahar
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2014, 80 (01): : 93 - 95
  • [7] Imatinib mesylate-induced maculopapular drug rash
    Dogra, S
    Kanwar, AJ
    NATIONAL MEDICAL JOURNAL OF INDIA, 2003, 16 (05): : 285 - 286
  • [8] Imatinib Mesylate-Induced Hyperpigmentation of the Nose and Palate
    Song, Hyo Sang
    Kang, Hee Young
    ANNALS OF DERMATOLOGY, 2014, 26 (04) : 532 - 533
  • [9] Imatinib mesylate-induced neutrophilic folliculitis in a teenager
    Teresa Garcia-Romero, Maria
    Duran-McKinster, Carola
    Saez de Ocariz, Marimar
    Carrasco-Daza, Daniel
    Palacios-Lopez, Carolina
    Orozco-Covarrubias, Luz
    Ruiz-Maldonado, Ramon
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2012, 51 (12) : 1529 - 1530
  • [10] Imatinib Mesylate-Induced Lichenoid Drug Eruption
    Penn, Erin H.
    Chung, Hye Jin
    Keller, Matthew
    CUTIS, 2017, 99 (03): : 189 - +